Eden vs Hims & Hers
Two GLP-1 providers, one scoreboard. We put Eden and Hims & Hers head-to-head on the published Brief Score — the same six factors, scored the same way.
Eden
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.
Hims & Hers
FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.
The verdict
Eden takes this head-to-head.
Eden scores 91 to 85 on our six-factor Brief Score — A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.
That doesn't make Hims & Hers a bad call — it's best for readers who want a familiar, app-driven consumer brand and nationwide access. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Eden | Hims & Hers | |
|---|---|---|
| Brief Score | 91/100 (A−) | 85/100 (B) |
| Semaglutide | $198/mo all-in — $99/mo for the medication plus the $99/mo Eden membership it cannot be bought without ($138 the first month, when membership is $39); compounded | $199/mo |
| Tirzepatide | $298/mo all-in — $199/mo for the medication plus the required $99/mo membership ($238 the first month); compounded | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Fallingprice falling | Risingprice rising |
Eden: Re-read 28 August 2026 and restated: Eden advertises compounded semaglutide at $99/mo and tirzepatide at $199/mo, but its own footnote says medication cannot be bought without an Eden membership that costs $39 the first month and $99/mo after — so the real monthly cost is $198 and $298. That is below the $239 and $349 we carried before, so the direction is down even after adding the fee back in. Brand-name Ozempic, Zepbound and Mounjaro ($1,399/mo) and Wegovy ($1,695/mo) are sold here too.
Hims & Hers: App-first reach is nationwide, but compounded supply has drawn industry-wide scrutiny.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.